# Carbamylation in Renal Disease-modulation With Amino Acid Therapy

> **NCT01612429** · EARLY_PHASE1 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 23 (actual)

## Conditions studied

- End Stage Renal Failure on Dialysis

## Interventions

- **DIETARY_SUPPLEMENT:** Amino acid supplementation

## Key facts

- **NCT ID:** NCT01612429
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-01
- **Primary completion:** 2015-07
- **Final completion:** 2015-07
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2016-11-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01612429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01612429, "Carbamylation in Renal Disease-modulation With Amino Acid Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01612429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*